Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer
Study Type
OBSERVATIONAL
Enrollment
200
CHRU de Brest
Brest, France
RECRUITINGCH Morlaix, service d'hémato clinique
Morlaix, France
RECRUITINGCHIC, service d'hémato clinique
Quimper, France
RECRUITINGEstablish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer
identification of anomalies by mapping identical to those identified by combining conventional cytogenetics and FISH.
Time frame: 2021-2026
identification of new chromosomal abnormalities of clinical relevance.
Time frame: 2021-2026
identification of new chromosomal anomalies involved in oncogenic pathways
Time frame: 2021-2026
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CH St Brieuc, service d'hémato clinique
Saint-Brieuc, France
RECRUITING